Lysine-rich histone (H1) is a lysyl substrate of tissue transglutaminase: Possible involvement of transglutaminase in the formation of nuclear aggregates in (CAG)(n)/Q(n) expansion diseases

Citation
Ajl. Cooper et al., Lysine-rich histone (H1) is a lysyl substrate of tissue transglutaminase: Possible involvement of transglutaminase in the formation of nuclear aggregates in (CAG)(n)/Q(n) expansion diseases, DEV NEUROSC, 22(5-6), 2000, pp. 404-417
Citations number
61
Categorie Soggetti
Neurosciences & Behavoir
Journal title
DEVELOPMENTAL NEUROSCIENCE
ISSN journal
03785866 → ACNP
Volume
22
Issue
5-6
Year of publication
2000
Pages
404 - 417
Database
ISI
SICI code
0378-5866(200009/12)22:5-6<404:LH(IAL>2.0.ZU;2-Z
Abstract
Histone H1,which contains about 27% lysine, is an excellent lysyl donor sub strate of Ca2+-activated guinea pig liver tissue transglutaminase as judged by rapid fluorescence enhancement in the presence of the glutaminyl-donor substrate 1-N-(carbobenzoxy-L-glutaminylglycyl)-5-N-(5'N'N'-dimethytaminona phthelenesulfonyl)diamidopentane, Sodium dodecyl sulfate get electrophoresi s of a 30-min reaction mixture revealed the presence of fluorescent high-M- r aggregates, which are also formed when histone H1 is incubated solely wit h activated tissue transglutaminase. Aggregate formation is even more prono unced when histone H1 is incubated with activated tissue transglutaminase a nd dimethylcasein (glutaminyl donor only). The findings suggest not only th at histone H1 is an especially good lysyl substrate of tissue transglutamin ase, but that it is also a glutaminyl substrate. Histone H1 is a good lysyl substrate of transglutaminase purified from Streptoverticillium mobaraense , suggesting that the ability of histone H1 to act as a transglutaminase ly syl substrate is widespread. In agreement with previous studies, it was fou nd that human P-endorphin is a moderately good substrate of tissue transglu taminase. At least 8 neurodegenerative diseases, including Huntington's dis ease, are caused by (CAG)(n) expansions in the genome and by an expansion o f the corresponding polyglutamine domain within the expressed, mutated prot ein. Polyglutamine domains are excellent substrates of river and brain tran sglutaminases. A hallmark of many of the (CAG)(n)/polyglutamine expansion d iseases is the presence of polyglutamine-containing aggregates within the c ytosol and nuclei of affected neurons. Transglutaminase activity occurs in both of these compartments in human brain. In future studies, it will be im portant to determine whether transglutaminases play a role in (1)cross-link ing of histone H1 to glutaminyl donors (including polyglutamine domains) in nuclear chromatin, (2) the formation of nuclear aggregates in (CAG)(n)/pol yglutamine expansion diseases, (3) DNA laddering and cell death in neurodeg enerative diseases and (4) depletion of neuropeptides in vulnerable regions of Huntington's disease brain. Copyright (C) 2000 S. Karger AG. Basel.